CIK 0000882796 · Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 621413174
- Phone
- 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- 8-A12G Other 8-A12G
- 8-K Event Item 5 · Item 7
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- DEF 14A Proxy Proxy Statement
- 10-K405 Other 10-K405
- SC 13G/A Stake Amended Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 10-Q/A Report 10-Q/A
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
- 8-K Event Item 5 · Item 7
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- SC 13G Stake Amended Statement of Ownership
Page 96 of 99 · 1,967 filings